The enzymatic b-C-H hydroxylation of the feedstock chemical isobutyric acid has enabled the asymmetric synthesis of a wide variety of polyketides. The analogous transition metal-catalyzed enantioselective b-C-H functionalization of isobutyric acid-derived substrates should provide a versatile method for constructing useful building blocks with enantioenriched a-chiral centers from this abundant C-4 skeleton. However, the desymmetrization of ubiquitous isopropyl moieties by organometallic catalysts has remained an unanswered challenge. Herein, we report the design of chiral mono-protected aminomethyl oxazoline ligands that enable desymmetrization of isopropyl groups via palladium insertion into the C(sp 3 )-H bonds of one of the prochiral methyl groups. We detail the enantioselective b-arylation, -alkenylation, and -alkynylation of isobutyric acid/2-aminoisobutyric acid derivatives, which may serve as a platform for the construction of a-chiral centers.
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The enzymatic b-C-H hydroxylation of the feedstock chemical isobutyric acid has enabled the asymmetric synthesis of a wide variety of polyketides. The analogous transition metal-catalyzed enantioselective b-C-H functionalization of isobutyric acid-derived substrates should provide a versatile method for constructing useful building blocks with enantioenriched a-chiral centers from this abundant C-4 skeleton. However, the desymmetrization of ubiquitous isopropyl moieties by organometallic catalysts has remained an unanswered challenge. Herein, we report the design of chiral mono-protected aminomethyl oxazoline ligands that enable desymmetrization of isopropyl groups via palladium insertion into the C(sp 3 )-H bonds of one of the prochiral methyl groups. We detail the enantioselective b-arylation, -alkenylation, and -alkynylation of isobutyric acid/2-aminoisobutyric acid derivatives, which may serve as a platform for the construction of a-chiral centers. R eactions of C-H activation enable the use of minimally functionalized bulk chemicals as building blocks for the synthesis of complex molecules, thereby shortening synthetic sequences, reducing waste, and improving the sustainability of chemical synthesis. For the logic of C-H activation to be fully realized in the synthesis of chiral molecules, enantioselective C-H activation reactions-whereby stereochemistry is controlled in the C-H cleavage step by a metal catalyst-must be developed (1) . The biosynthetic pathways to a myriad of natural products proceed through the enantioselective b-C-H hydroxylation of isobutyric acid (2, 3) . Further, this process has been adapted for the industrial preparation of the Roche ester, which has served as an invaluable source of a-center chirality in the synthesis of complex molecules (4-7) (Fig. 1A) . Inspired by the bulk preparation of the Roche ester and the central role of a-chiral centers in retrosynthetic analysis (8) , our group has long sought to develop methodologies that desymmetrize the isopropyl group of isobutyric acid derivatives through transition metal-catalyzed C-H functionalization, in turn expanding the existing chiral pool (Fig. 1B) .
Although enantioselective b-methylene C-H arylation has recently been realized (9) , desymmetrization of isopropyl groups is a fundamentally different challenge. This challenge is reflected in an analysis of the steric environment associated with respective C-H insertion intermediates I and II (Fig. 1C) . In methylene C-H activation (I), steric differentiation between a bulky alkyl group and a methylene C-H bond is required, whereas in the desymmetrization of isopropyl moieties (II), the a hydrogen atom must be differentiated from a relatively small a-methyl substituent. Moreover, the prochiral center (the a carbon) in isopropyl desymmetrization is too far away to interact directly with the ligated transition metal catalyst, making asymmetric induction considerably more challenging.
To date, intermolecular desymmetrization of a-dialkyl groups has only been possible with cyclopropane, cyclobutane, or substrates containing large a substituents, which serve to amplify the chiral recognition in the transition state (10) (11) (12) (13) . Related studies from other laboratories on the desymmetrization of a-dialkyl groups via C-H activation have been limited to intramolecular Pd(0)-catalyzed C-H arylations (14) (15) (16) (17) (18) (19) (20) (21) (22) . An inspiring formal enantioselective intermolecular b-arylation of isobutyric esters has been demonstrated with moderate enantioselectivity [67:33 to 77:23 enantiomeric ratio (er)] (23). In this reaction, a-lithiation precedes a-palladation, which is followed by b-hydride elimination to give the corresponding olefin intermediate. Subsequent enantioselective carbopalladation of the double bond, rather than chiral recognition of geminal methyl groups, is responsible for chiral induction.
Here we report the design of chiral monoprotected aminomethyl oxazoline (MPAO) ligands that enable Pd(II)-catalyzed enantioselective b-arylation, -alkenylation, and -alkynylation of isobutyric amides (Fig. 1B) . The remaining 2 (where OAc is acetate), 20 mol % L30, Ar-I (where Ar is an aryl group), Ag 2 CO 3 , toluene, 50°C, 72 hours. Ar F , 4-(CF 3 )C 6 F 4 ; p-Tol-I, para-tolyl iodide; equiv., equivalent; Et, ethyl group; Ph, phenyl group; Ac, acetyl group; Ar(Het), (hetero)aryl group; TBS, tert-butyldimethylsilyl group; Bn, benzyl group; Boc, tertbutyloxycarbonyl group; Ts, tosyl group; Phth, phthalimido group; HFIP, hexafluoro-2-propanol; TFA, trifluoroacetate. a-methyl group can then undergo further C-H functionalizations to afford greater product diversity. Using a chiral benzoyl-protected aminomethyl oxazoline ligand, desymmetrization of 2-aminoisobutyric acid-derived amide (3) is also showcased to provide straightforward access to a wide range of enantioenriched a,a-dialkyl a-amino acids that may be used as building blocks for peptide-based drug synthesis (24, 25) . Systematic ligand modification suggests that the additional interaction of the chiral center on the oxazoline ring with the substrate is crucial to the successful desymmetrization of isopropyl groups.
Our early efforts to desymmetrize isopropyl groups of isobutyric acid-derived substrates focused on the use of chiral auxiliaries (10, 11) . These studies, through isolation of well-defined chiral C-H insertion intermediates and computational analysis (26, 27) , improved our understanding of how chiral differentiation of a-gem-dimethyl groups could potentially be achieved (Fig. 1C) . The difficulty of desymmetrizing the gem-dimethyl groups in isobutyric acid-derived substrates is demonstrated by the fact that even when employing a bulky oxazoline as a chiral auxiliary, no diastereoselectivity is obtained (10) . Furthermore, desymmetrization of a-dimethyl groups using a chiral amino acid-derived ligand is only successful (90:10 er) when the a hydrogen atom is replaced by an extremely bulky a-tert-butyl group (12) . The use of chiral phosphoric acid ligands has also failed to enantioselectively differentiate the gem-dimethyl groups in isobutyric acid-derived substrates (28) (29) (30) (31) .
Our recent development of bidentate chiral acetyl-protected aminoethyl quinoline (APAQ, L1) ligands for enantioselective methylene C-H activation prompted us to test whether these ligands would prove useful for the desymmetrization of isopropyl groups in isobutyric acid-derived amides (9) . With isobutyric amide substrate 1, L1 produced nearly racemic products ( Fig. 2A) . Furthermore, extensive modification of APAQ ligands did not lead to a noticeable improvement in enantiomeric ratio (er). This result highlights the difference between the desymmetrization of isopropyl groups and enantioselective methylene C-H activation. To amplify steric interactions between substrate and catalyst, we replaced the quinoline motif with oxazoline, thereby enabling introduction of additional chiral bias to the catalyst. Ligand L2-consisting of an achiral oxazoline moiety, a bulky isopropyl stereocenter (derived from valine), and an N-acetyl-protected aminefailed to achieve significant stereoinduction. Further, the chiral oxazoline ligand L3 derived from N-acetyl glycine, and consequently lacking a stereocenter on the ligand backbone, also failed to afford enantioenriched products. The combination of the two chiral centers at C-4 on the oxazoline and the side chain in L22 afforded a promising er of 85:15. Increasing the steric bulkiness on the side chain (i.e., from isopropyl to tert-butyl, L23) further improved the selectivity to 98:2 er (for extensive optimizations of chiral ligands, Pd source, additives, and reaction concentrations, see tables S1 to S5). The synergistic effect of the mutual relationship between these two stereocenters is evident from the complete loss of enantioselectivity when the absolute stereochemistry of one of the chiral centers is reversed, as in L24. Although full rationalizations of the observed asymmetric induction require extensive computational and kinetic analysis, the absolute configuration of the product and the observed influence of each chiral center on the effectiveness of the ligands are consistent with the steric interactions indicated in the C-H insertion intermediate III (Fig. 1C) . We propose that the N-acetyl group on the coordinating nitrogen is oriented on the top face of the palladium square plane due to steric repulsion from the chiral center on the side chain. The 4-benzyl group on the oxazoline ring further shields the top face of intermediate III. These combined steric interactions may reinforce the orientation of the a-methyl group in III, thereby establishing the stereochemistry of the C-H cleavage step.
With the optimized chiral ligand and conditions in hand, we screened the enantioselective b-C-H arylation of isobutyric amide 1 with a wide range of aryl iodides (Fig. 2B) . A range of para-substituents on the aryl iodides from electron-donating (OMe and NBnBoc) to electronwithdrawing (halides, CF 3 , keto, and nitro) groups are tolerated, providing enantioselectivity up to 98:2 er (2a to 2q). The scope of meta-substituted aryl iodides is also broad, and enantiomeric ratios greater than 94:6 (2r to 2ab) were obtained. The above scope of ortho-, meta-, and para-substituted aryl iodides features either halogens (as in 2l to 2n, 2u to 2w, and 2ah) or reactive groups (phosphonate moiety as in 2i and aldehyde functionality as in 2aa and 2ae) that can serve as useful synthetic handles for subsequent chemical manipulation. A number of heteroaryl iodidesincluding thiophene, benzothiophene, and indole moieties-are also compatible, affording products with high enantioselectivity in synthetically useful yields (2al to 2ap). The simplicity of deprotecting the amide auxiliary using BF 3 ·Et 2 O was also demonstrated with product 2q without erosion in enantioselectivity (see supplementary materials for experimental details).
The distinct pharmacological and conformational properties of a,a-disubstituted a-amino acids displayed in peptide drug molecules (24, 25) prompted us to apply these conditions to Nphthaloyl-protected 2-aminoisobutyric acid derivatives (Fig. 2C) . However, the analogous amide substrate prepared by condensing the N-Phth-protected 2-aminoisobutyric acid with 2,3,5,6-tetrafluoro-4-(trifluoromethyl)aniline is not reactive under these conditions, presumably due to the steric bulkiness of this substrate, which may prevent coordination. To reduce the steric hindrance of the substrate, we prepared the N-methoxy amide 3 of N-phthaloyl-protected 2-aminoisobutyric acid (32, 33) (Fig. 2C) . Although 3 showed substantial decomposition under the conditions established for substrate 1, we were able to find milder conditions that allowed the b-arylation to proceed at 35°C. Although ligand L23 gave satisfactory enantioselectivity (91:9 er), the yield remained low (~40%) despite extensive optimizations. We next elected to screen MPAO ligands. Whereas modification of the oxazoline ring and the amino acid side chain afforded only moderate improvement in yields (see supplementary materials for experimental details), replacement of the N-acetyl moiety by an orthodifluorobenzoyl group (L41) increased the yield of 4a to 75% while maintaining high enantioselectivity (Fig. 2C, 96 :4 er). C-H coupling with a variety of aryl iodides afforded difficult-to-access enantioenriched a,a-disubstituted a-amino acids containing chiral a-quaternary centers (4a to 4f; for coupling with a wide range of aryl iodides, see fig. S1 ). The facile conversion of the N-methoxy amide auxiliary to an ester renders this method easy to use (32) . On the gram scale, both the N-methoxy amide auxiliary and the Phth protecting group were removed and converted to the fluorenylmethyloxycarbonyl-protected amino acid as a building block for peptide synthesis (see supplementary materials).
One potential advantage of an organometallic approach to enantioselective functionalizations of C(sp 3 )-H bonds is that the metallated intermediate can undergo reactivity with various coupling partners. Unfortunately, Pd-catalyzed enantioselective C(sp 3 )-H activation reactions have been limited to arylation thus far. To fully realize the potential of asymmetric metal insertion processes, we next developed enantioselective C-H alkenylation and alkynylation reactions of 1. b-Styrenylation of amide 1 using chiral ligand L23 afforded 88:12 er (Fig. 3) . The use of L30 containing an additional chiral center at C-5 improved the enantioselectivity to 94:6 er. A number of (E)-styrenyl iodides (5a to 5s) are compatible coupling partners, as is the disubstituted (E)-styrenyl iodide (5t). The use of other simple (E)-alkenyl iodides also resulted in good enantioselectivity, albeit in lower yields (5u and 5v). Upon minor alteration of reaction conditions, L30 allowed the enantioselective b-alkynylation to proceed in 94.5:5.5 er (6). To further broaden the diversity of the chiral centers accessed through these three enantioselective transformations, we also performed subsequent diverse b-functionalizations-including arylation (7a to 7f), alkynylation (8) , alkylation (9), bromination (10), and borylation (11)-of the remaining methyl group (Fig. 4) . Thus, the sequential C-H functionalizations of the isopropyl groups with a wide range of coupling partners afford a myriad of a-chiral carboxylic acids.
Our success in the steric differentiation of a hydrogen atom and a relatively small methyl group by an organometallic catalyst provides invaluable insight for the further development of desymmetrizing enantioselective C-H activation reactions. The enantioselective b-C-H activation reactions reported herein provide a versatile platform for constructing a-chiral centers in asymmetric synthesis. 
